A twelve-month projection to September 2022 of the Covid-19 epidemic in the UK using a Dynamic Causal Model
Bowie, C.; Friston, K.
Show abstract
ObjectivesPredicting the future UK Covid-19 epidemic allows other countries to compare their epidemic with one unfolding without public health measures except a vaccine programme. MethodsA Dynamic Causal Model (DCM) is used to estimate the model parameters of the epidemic such as vaccine effectiveness and increased transmissibility of alpha and delta variants, the vaccine programme roll-out and changes in contact rates. The model predicts the future trends in infections, long-Covid, hospital admissions and deaths. ResultsTwo dose vaccination given to 66% of the UK population prevents transmission following infection by 44%, serious illness by 86% and death by 93%. Despite this, with no other public health measures used, cases will increase from 37 million to 61 million, hospital admission from 536,000 to 684,000 and deaths from 136,000 to 142,000 over twelve months. DiscussionVaccination alone will not control the epidemic. Relaxation of mitigating public health measures carries several risks - overwhelming the health services, the creation of vaccine resistant variants and the economic cost of huge numbers of acute and chronic cases.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The effectiveness of Non Pharmaceutical Interventions in reducing the outcomes of the COVID-19 epidemic in the UK, an observational and modelling study 96%
- Community structured model for vaccine strategies to control COVID19 spread: a mathematical study 95%
- The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement 95%
Similar papers in this journal
- Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 97%
- Modelling the impact of hybrid immunity on future COVID-19 epidemic waves 95%
- Modelling testing and response strategies for COVID-19 outbreaks in remote Australian Aboriginal communities 94%
Similar papers in this journal
- Exploring the role of mass immunisation in influenza pandemic preparedness: a modelling study for the UK context 97%
- Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework 95%
- Measuring the impact of COVID-19 vaccination and immunity waning: a modelling study for Portugal 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.